Being
announced as one of the “2019 Top Ten Emerging Technologies
in Chemistry” by IUPAC, the directed evolution of artificial
metalloenzymes has led to a broad scope of abiotic processes. Here,
inspired by those key proteins in bioluminescence, a rudimentary expression
of bio-electrochemiluminescent (ECL) macromolecules was achieved via
the complexation of zinc proto-porphyrin IX (ZnPPIX)
within apo-hemoglobin (apo-Hb).
A high-yield monochromic irradiation at 644 nm could be provoked potentiostatically
from the reconstituted holo-HbZnPPIX in
solutions. Its secondary structure integrity was elucidated by UV
and circular dichroism spectrometry, while voltammetry-hyphenated
surface plasmon resonance authenticated its ligation conservativeness
in electrical fields. Further conjugation with streptavidin rendered
a homogeneous Janus fusion of both receptor and reporter domains,
enabling a new abiological catalyst-linked ECL bioassay. On the other
hand, singular ZnPPIX inside each tetrameric subunit of Hb accomplished
an overall signal amplification without the bother of luminogenic
heterojunctions. This pH-tolerant and non-photobleaching optics was
essentialized to be the unique configuration interaction between Zn
and O2, by which the direct electrochemistry of proteins
catalyzed the transient progression of O2 → O2
·– → O2* + hυ selectively. Such principle was implemented
as a signal-on strategy for the determination of a characteristic
cancer biomarker, the vascular endothelial growth factor, resulting
in competent performance at a low detection limit of 0.6 pg·mL–1 and a wide calibration range along with good stability
and reliability in real practices. This simple mutation repurposed
the O2-transport Hb in the erythrocytes of almost all vertebrates
into a cluster of oxidoreductases with intrinsic ECL activity, which
would enrich the chromophore library. More importantly, its genetically
engineered variants may come in handy in biomedical diagnosis and
visual electrophysiology.